Rapid Regulatory T-Cell Response Prevents Cytokine Storm in CD28 Superagonist Treated Mice

Superagonistic CD28-specific monoclonal antibodies (CD28SA) are highly effective activators of regulatory T-cells (Treg cells) in rats, but a first-in-man trial of the human CD28SA TGN1412 resulted in an unexpected cytokine release syndrome. Using a novel mouse anti-mouse CD28SA, we re-investigate t...

Descripción completa

Detalles Bibliográficos
Autores principales: Gogishvili, Tea, Langenhorst, Daniela, Lühder, Fred, Elias, Fernando, Elflein, Karin, Dennehy, Kevin M., Gold, Ralf, Hünig, Thomas
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2645706/
https://www.ncbi.nlm.nih.gov/pubmed/19247496
http://dx.doi.org/10.1371/journal.pone.0004643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2645706/
https://www.ncbi.nlm.nih.gov/pubmed/19247496
http://dx.doi.org/10.1371/journal.pone.0004643

Ejemplares similares